Validation of tissue microarrays in oral epithelial dysplasia using a novel virtual-array technique

Journal of Clinical Pathology

Volumn 65, Issue 12, 2012, Pages 1084-1087

  Nankivell, Paul Christopher ^a   Williams, Hazel ^a,b   Bartlett, John M S ^c   Mehanna, Hisham ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD151 ANTIGEN; CD82 ANTIGEN; CD9 ANTIGEN; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P16;

ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INTEROBSERVER RELIABILITY; MALE; MALIGNANT TRANSFORMATION; MOUTH DISEASE; ORAL EPITHELIAL DYSPLASIA; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; TISSUE MICROARRAY; VIRTUAL TISSUE MICROARRAY;

ADULT; ANTIGENS, CD; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MOUTH DISEASES; MOUTH MUCOSA; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TISSUE ARRAY ANALYSIS; USER-COMPUTER INTERFACE;

EID: 84870061581     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-200974     Document Type: Article

References (31)

1. der Waal van I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 2009;45:317-23.
2. Fleskens S, Slootweg P. Grading systems in head and neck dysplasia: their prognostic value, weaknesses and utility. Head Neck Oncol 2009;1:11.
3. Eguíluz C, Viguera E, Millán L, et al. Multitissue array review: a chronological description of tissue array techniques, applications and procedures. Pathol Res Pract 2006;202:561-8. (Pubitemid 44057769)
4. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7. (Pubitemid 28331029)
5. Wan WH, Fortuna MB, Furmanski P. A rapid and efficient method for testing immunohistochemical reactivity of monoclonal antibodies against multiple tissue samples simultaneously. J Immunol Methods 1987;103:121-9. (Pubitemid 17139428)
6. Sauter G, Mirlacher M. Tissue microarrays for predictive molecular pathology. J Clin Pathol 2002;55:575-6.
7. Rosen DG, Huang X, Deavers MT, et al. Validation of tissue microarray technology in ovarian carcinoma. Mod Pathol 2004;17:790-7. (Pubitemid 38843361)
8. Alkushi A. Validation of tissue microarray biomarker expression of breast carcinomas in Saudi women. Hematol Oncol Stem Cell Ther 2009;2:394-8.
9. Jourdan F, Sebbagh N, Comperat E, et al. Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression. Virchows Arch 2003;443:115-21. (Pubitemid 37056134)
10. Karlsson C, Bodin L, Piehl-Aulin K, et al. Tissue microarray validation: a methodologic study with special reference to lung cancer. Cancer Epidemiol Biomarkers Prev 2009;18:2014-21.
11. Sun Y, Li J-Y, He J-S, et al. Tissue microarray analysis of multiple gene expression in intestinal metaplasia, dysplasia and carcinoma of the stomach. Histopathology 2005;46:505-14. (Pubitemid 40632307)
12. Gomaa W, Ke Y, Fujii H, et al. Tissue microarray of head and neck squamous carcinoma: validation of the methodology for the study of cutaneous fatty acid-binding protein, vascular endothelial growth factor, involucrin and Ki-67. Virchows Arch 2005;447:701-9. (Pubitemid 41571185)
13. Goldstein NS, Hewitt SM, Taylor CR, et al. Recommendations for improved standardization of immunohistochemistry. Appl Immunohistochem Mol Morphol 2007;15:124-33. (Pubitemid 46828218)
14. Kirkegaard T, Edwards J, Tovey S, et al. Observer variation in immunohistochemical analysis of protein expression, time for a change? Histopathology 2006;48:787-94. (Pubitemid 43800937)
15. Carrasco JL, Jover L. Estimating the generalized concordance correlation coefficient through variance components. Biometrics 2003;59:849-58. (Pubitemid 38021213)
16. Cicchetti DV, Sparrow SA. Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior. Am J Ment Defic 1981;86:127-37. (Pubitemid 11006962)
17. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74. (Pubitemid 8054849)
18. Fillies T, Jogschies M, Kleinheinz J, et al. Cytokeratin alteration in oral leukoplakia and oral squamous cell carcinoma. Oncol Rep 2007;18:639-43.
19. Santos-García A, Abad-Hernández MM, Fonseca-Sánchez E, et al. E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2006;11:E100-5.
20. Kaur J, Sawhney M, DattaGupta S, et al. Clinical significance of phosphatidyl inositol synthase overexpression in oral cancer. BMC Cancer 2010;10:168.
21. Ryott M, Wangsa D, Heselmeyer-Haddad K, et al. EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma. Eur J Cancer 2009;45:1700-8.
22. Chan G, Boyle JO, Yang EK, et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999;59:991-4. (Pubitemid 29135955)
23. Buim MEC, Lourenço SV, Carvalho KC, et al. Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma. Oral Oncol 2010;46:166-71.
24. Farhadieh RD, Smee R, Ow K, et al. Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival. Cancer Lett 2004;213:91-8. (Pubitemid 39127412)
25. Hirano C, Nagata M, Noman AA, et al. Tetraspanin gene expression levels as potential biomarkers for malignancy of gingival squamous cell carcinoma. Int J Cancer 2009;124:2911-16.
26. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24-35.
27. Boone J, Hillegersberg R, Diest PJ, et al. Validation of tissue microarray technology in squamous cell carcinoma of the esophagus. Virchows Arch 2008;452:507-14.
28. Cunha KSG, Caruso AC, Gonçalves AS, et al. Validation of tissue microarray technology in malignant peripheral nerve sheath tumours. J Clin Pathol 2009;62:629-33.
29. Fons G, der Velden van J, Burger M, et al. Validation of tissue microarray technology in vulvar cancer. Int J Gynecol Pathol 2009;28:76-82.
30. Hecht JL, Kotsopoulos J, Gates MA, et al. Validation of tissue microarray technology in ovarian cancer: results from the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev 2008;17:3043-50.
31. Parsons M, Grabsch H. How to make tissue microarrays. Diagn Histopathol 2009;15:142-50.